Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
02 2019
Historique:
received: 01 12 2017
accepted: 05 12 2018
pubmed: 1 2 2019
medline: 25 7 2019
entrez: 1 2 2019
Statut: ppublish

Résumé

The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways

Identifiants

pubmed: 30700910
doi: 10.1038/s41586-018-0849-9
pii: 10.1038/s41586-018-0849-9
pmc: PMC6367023
mid: NIHMS1515990
doi:

Substances chimiques

Glp1r protein, mouse 0
Glucagon-Like Peptide-1 Receptor 0
Integrin beta Chains 0
integrin beta7 0
Glucagon-Like Peptide 1 89750-14-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

115-119

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL131478
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128264
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL135752
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI118692
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Begg, D. P. & Woods, S. C. The endocrinology of food intake. Nat. Rev. Endocrinol. 9, 584–597 (2013).
doi: 10.1038/nrendo.2013.136
Drucker, D. J. The cardiovascular biology of glucagon-like peptide-1. Cell Metab. 24, 15–30 (2016).
doi: 10.1016/j.cmet.2016.06.009
Cerf-Bensussan, N., Bègue, B., Gagnon, J. & Meo, T. The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a β7 subunit associated with a distinctive α chain. Eur. J. Immunol. 22, 273–277 (1992).
doi: 10.1002/eji.1830220140
Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445–456 (2011).
doi: 10.1038/nri3007
Holzmann, B., McIntyre, B. W. & Weissman, I. L. Identification of a murine Peyer’s patch—specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell 56, 37–46 (1989).
doi: 10.1016/0092-8674(89)90981-1
Holzmann, B. & Weissman, I. L. Peyer’s patch-specific lymphocyte homing receptors consist of a VLA-4-like α chain associated with either of two integrin β chains, one of which is novel. EMBO J. 8, 1735–1741 (1989).
doi: 10.1002/j.1460-2075.1989.tb03566.x
Parker, C. M. et al. A family of β
doi: 10.1073/pnas.89.5.1924
Gorfu, G., Rivera-Nieves, J. & Ley, K. Role of β7 integrins in intestinal lymphocyte homing and retention. Curr. Mol. Med. 9, 836–850 (2009).
doi: 10.2174/156652409789105525
Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570–586 (2017).
doi: 10.1016/j.cell.2017.04.004
Johnson, A. M. & Olefsky, J. M. The origins and drivers of insulin resistance. Cell 152, 673–684 (2013).
doi: 10.1016/j.cell.2013.01.041
Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111–2117 (2011).
doi: 10.1172/JCI57132
Odegaard, J. I. & Chawla, A. The immune system as a sensor of the metabolic state. Immunity 38, 644–654 (2013).
doi: 10.1016/j.immuni.2013.04.001
Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161–166 (2013).
doi: 10.1126/science.1230719
Swirski, F. K. et al. Ly-6C
doi: 10.1172/JCI29950
Hilgendorf, I. & Swirski, F. K. Making a difference: monocyte heterogeneity in cardiovascular disease. Curr. Atheroscler. Rep. 14, 450–459 (2012).
doi: 10.1007/s11883-012-0274-8
Berlin, C. et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185–195 (1993).
doi: 10.1016/0092-8674(93)90305-A
Wagner, N. et al. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 382, 366–370 (1996).
doi: 10.1038/382366a0
Schön, M. P. et al. Mucosal T lymphocyte numbers are selectively reduced in integrin α
pubmed: 10352281
Uehara, S., Grinberg, A., Farber, J. M. & Love, P. E. A role for CCR9 in T lymphocyte development and migration. J. Immunol. 168, 2811–2819 (2002).
doi: 10.4049/jimmunol.168.6.2811
Lycke, N. Y. & Bemark, M. The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol. 10, 1361–1374 (2017).
doi: 10.1038/mi.2017.62
Fagarasan, S. & Honjo, T. Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol. 3, 63–72 (2003).
doi: 10.1038/nri982
Baggio, L. L. & Drucker, D. J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131–2157 (2007).
doi: 10.1053/j.gastro.2007.03.054
Kahles, F. et al. GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering. Diabetes 63, 3221–3229 (2014).
doi: 10.2337/db14-0100
Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016).
doi: 10.1056/NEJMoa1603827
Marso, S. P. et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834–1844 (2016).
doi: 10.1056/NEJMoa1607141
Yusta, B. et al. GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes 64, 2537–2549 (2015).
doi: 10.2337/db14-1577
Lamont, B. J. et al. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J. Clin. Invest. 122, 388–402 (2012).
doi: 10.1172/JCI42497
Arakawa, M. et al. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes 59, 1030–1037 (2010).
doi: 10.2337/db09-1694
Nagashima, M. et al. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia 54, 2649–2659 (2011).
doi: 10.1007/s00125-011-2241-2
Kim, M. et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat. Med. 19, 567–575 (2013).
doi: 10.1038/nm.3128

Auteurs

Shun He (S)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SHE6@mgh.harvard.edu.

Florian Kahles (F)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Sara Rattik (S)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Manfred Nairz (M)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Cameron S McAlpine (CS)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Atsushi Anzai (A)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Daniel Selgrade (D)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Ashley M Fenn (AM)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Christopher T Chan (CT)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

John E Mindur (JE)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Colin Valet (C)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Wolfram C Poller (WC)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Lennard Halle (L)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Noemi Rotllan (N)

Vascular Biology and Therapeutics Program, Department of Comparative Medicine and Pathology, Yale University School of Medicine, New Haven, CT, USA.

Yoshiko Iwamoto (Y)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Gregory R Wojtkiewicz (GR)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Ralph Weissleder (R)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Systems Biology, Harvard Medical School, Boston, MA, USA.

Peter Libby (P)

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Carlos Fernández-Hernando (C)

Vascular Biology and Therapeutics Program, Department of Comparative Medicine and Pathology, Yale University School of Medicine, New Haven, CT, USA.

Daniel J Drucker (DJ)

Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Matthias Nahrendorf (M)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Filip K Swirski (FK)

Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. fswirski@mgh.harvard.edu.
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. fswirski@mgh.harvard.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH